Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113214267B reveals a novel one-step crystallization method for eszopiclone, offering high purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104151249B details a high-purity chiral resolution method using camphorsulfonic acid, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN111004179B details a high-purity resolution method for 5'-methoxylaudanosine, offering superior yield and optical purity for neuromuscular blocker synthesis.
Patent CN1950326A details a high-yield optical resolution and recycling process for atomoxetine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Strecker reaction route for Clopidogrel bisulfate. High yield, scalable process for pharmaceutical intermediates manufacturing.
Novel asymmetric conversion method boosts yield to over 80 percent for L-2-aminobutyric acid, offering cost-effective pharma intermediate supply.
Advanced preparation method for Pitavastatin Calcium offering high yield and simplified purification for reliable API supply chains and cost-effective manufacturing.
Novel pH-dependent resolution method for Isavuconazole Intermediate 4 offering high purity and reduced operational complexity for pharmaceutical supply chains globally.
Patent CN114573411B reveals a safer synthesis route for Palonosetron intermediates, eliminating n-hexane and improving purity for reliable pharmaceutical intermediates supplier partnerships.
Novel catenane resolving agent method ensures high ee values and scalable production for pharmaceutical intermediates.
Patent CN101143863B details a novel resolution method for (6S)-5-MTHF using alpha-phenylethylamine, offering high purity and reduced chloride contamination for pharmaceutical manufacturing.
Novel reductive amination route for Rivastigmine intermediate CN101016257A. Enhances yield and purity for API manufacturing supply chains.
Patent CN104781243A details a novel chiral synthesis for ribonolactone intermediates. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN112707901A reveals a cost-effective resolution method for moxifloxacin side chains using gulonic acid, offering >98% ee and simplified manufacturing for reliable API intermediate supply.
Patent CN103755624A reveals a novel synthesis method for piperidine derivatives, significantly improving yield and purity for Tofacitinib manufacturing while reducing costs.
Patent CN106632368A reveals a scalable total synthesis route for Irinotecan Hydrochloride, ensuring high purity and supply chain stability for global API manufacturers.
Patent CN102212081B details a novel asymmetric synthesis for statin side chains, offering high purity and eliminating resolution steps for cost-effective manufacturing.
Novel resolution method for argatroban starting material improves purity and yield. Offers supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN100341850C details a novel chiral resolution method for demethylphencynonate salts, enabling >98% optical purity for anti-motion sickness API manufacturing with reduced costs.
Patent CN1293039C reveals a superior method for [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative synthesis, offering enhanced yield and purity for ephedrine production.